Zhejiang Hisun Pharmaceutical Co., Ltd. Class ASSE: 600267

Announcement on the Wholly-Owned Subsidiary Receiving the CEP Certificate for Everolimus API

· Issued by Zhejiang Hisun Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Wholly-Owned Subsidiary Receiving the CEP Certificate for Everolimus API

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment